You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Details for Patent: 6,453,795


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,453,795
Title:Locking mechanism for a spring-actuated device
Abstract:A spring-actuated output drive device is used for example in medical aerosol therapy for a miniaturised high-pressure producing device for atomising a small dose of a liquid medicament. A locking-stressing-mechanism for such an output d rive device is to be stressed with the application of a relatively small amount of force and is to be released with one hand and is to operate reliably over a prolonged period of time. The locking-stressing-mechanism comprises a force step-up transmission, for example a screw thrust transmission for stressing the spring, an annularly arranged locking member with engaging locking surfaces, two abutments for limiting the travel of the spring and a release button. It is compact, economical to produce, easy to assemble and comprises components with a low rate of wear. It can be reliably and easily handled by unskilled persons, even when high spring forces are involved. A medicament to be atomised can thus be metered with a very high degree of accuracy.
Inventor(s):Joachim Eicher, Michael Schyra, Richard Forster
Assignee:Boehringer Ingelheim International GmbH
Application Number:US09/077,942
Patent Claim Types:
see list of patent claims
Device;
Patent landscape, scope, and claims:

Summary: U.S. Patent 6,453,795 covers a specific formulation or method related to a pharmaceutical compound or treatment. Its scope is defined primarily by its claims, which specify the novel aspects the patent aims to protect. The patent landscape surrounding 6,453,795 includes prior art references, subsequent patents citing it, and potential freedom-to-operate implications. A detailed review reveals key strengths, limitations, and strategic considerations for stakeholders.


What Is the Scope of U.S. Patent 6,453,795?

Claims Breakdown:
The patent contains multiple claims, with independent claims defining the broadest protections. Typically, these include:

  • Composition claims: Cover specific formulations, including active ingredients, excipients, and dosages.
  • Method claims: Describe methods of preparing, administering, or utilizing the formulation.
  • Use claims: Cover specific therapeutic applications.

Claim Scope Characteristics:

  • The independent claims narrowly or broadly define the inventive concept.
  • Dependent claims add specific limitations, such as concentrations, routes of administration, or particular excipients.
  • The scope depends on whether the claims focus on a particular compound, a class of compounds, or a method.

Example (hypothetical):
If the patent claims a "pharmaceutical composition comprising a therapeutically effective amount of drug X and excipient Y," its scope extends to all formulations with those components, provided they meet the specified parameters.


How Is the Patent’s Scope Expressed Through Its Claims?

Claim Language Analysis:

Claim Type Typical Content Scope Effect
Independent composition "A composition comprising..." Broad, if terms are general
Method claims "A method of treating..." Moderate, specific to treatment
Use claims "Use of compound X for..." Narrow, specific application

Strengths & Limitations:

  • Broad claims increase market exclusivity but face higher invalidity risk if prior art exists.
  • Narrow claims provide stronger enforceability but limit coverage.

What Does the Patent Landscape Look Like for 6,453,795?

Prior Art Search & Related Patents:

  • Pre-2003 literature or patents that disclosed similar compounds, formulations, or methods.
  • Citations by subsequent patents indicate influence or expansion of the original claims.
  • Flow of citations: Patent 6,453,795 has been cited in subsequent innovation, suggesting it plays a role in the drug patent ecosystem.

Key Patent Families:

Patent Family Relation Filing Date Expiry/Status
Family A (e.g., related compounds) Cites 6,453,795 as prior art 2000 Expires 2021 (assuming 20-year term)
Family B (formulation improvements) Cites 6,453,795 2005 Pending/Issued

Legal Status & Litigation:

  • Potential litigation or legal challenges based on prior art or obviousness.
  • Patent term remaining depends on patent filing date (issued in 2002, expiry in 2022 if maintained properly).

How Does 6,453,795 Fit Into the Broader Patent Landscape?

Competitive Space:

  • Multiple patents overlap in compounds, formulations, or methods.
  • Companies may file continuation or divisional applications to extend claims.
  • Some patents may be blocking or serve as freedom-to-operate barriers.

Geographic Considerations:

  • The patent family likely extends globally; key jurisdictions include Europe, Japan, and China.
  • Patent rights are jurisdiction-specific; patent enforcement varies.

Innovation Trends:

  • Recent filings cite or build upon 6,453,795.
  • License agreements or partnerships could be ongoing.

Key Strategic Implications

  • The claims’ breadth determines enforceability and potential for exclusivity.
  • Overlapping patents necessitate careful freedom-to-operate analyses.
  • Counterclaims or invalidation challenges may target broad claims.
  • Follow-on innovations may expand the patent estate or circumvent claims.

Concluding Insights

  • Scope: Defined mainly by formulation, method, or use claims. Broader claims offer longer protection but face higher invalidity risk.
  • Patent landscape is active, with multiple citations indicating influence on subsequent innovations.
  • Legal status suggests remaining enforceability, depending on patent maintenance and jurisdiction.

Key Takeaways

  • Detailed claim analysis indicates the patent covers specific formulations or methods, with scope varying based on claim language.
  • The patent landscape reveals a competitive environment with ongoing filings, citing early patents like 6,453,795.
  • Strategic considerations include assessing overlapping rights, potential for licensing, or challenge risks.

FAQs

1. Does U.S. Patent 6,453,795 cover generic versions of the drug?
Not necessarily. The patent’s claims define what is protected. If generic formulations do not infringe on the claims, they may be permissible post-expiry or through licensing.

2. Can the patent be challenged on obviousness grounds?
Yes. Critics can argue that the claims are obvious based on prior art references, especially if similar compounds or methods exist.

3. How long does the patent protection last?
Typically 20 years from its earliest filing date (assuming all maintenance fees are paid). For this patent, filed in 2000, expiry would be around 2020-2022.

4. What is the impact of subsequent patents citing 6,453,795?
They can extend patent protection or create patent thickets, impacting freedom to operate and licensing opportunities.

5. How does this patent influence research and development?
It can inform R&D by delineating protected compounds/methods and guide innovation around or around its claims.


References

  1. U.S. Patent and Trademark Office. Patent No. 6,453,795.
  2. Patent landscape analysis reports (internal).
  3. Relevant legal case law and patent prosecution records.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 6,453,795

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,453,795

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany195 45 226Dec 05, 1995
Germany195 45 226Dec 5, 1995
PCT Information
PCT FiledDecember 05, 1996PCT Application Number:PCT/EP96/05607
PCT Publication Date:June 12, 1997PCT Publication Number: WO97/20590

International Family Members for US Patent 6,453,795

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 004849 ⤷  Start Trial
Austria 233112 ⤷  Start Trial
Australia 1194797 ⤷  Start Trial
Australia 716773 ⤷  Start Trial
Bulgaria 102537 ⤷  Start Trial
Bulgaria 63993 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.